When we think about drug discovery, the words fast and efficient don’t usually come to mind - but a Singapore-based biotech startup is challenging that reality.
Nanyang Biologics is harnessing the power of AI and an extensive library of tropical bioactives to accelerate how we discover new treatments, not just for humans, but for animals too.
So how are they doing it?
On the Right Business, Hongbin Jeong speaks to Giang Nyugen, Chief Technology Officer of Nanyang Biologics (NYB), to find out more.

The Big Story: Is the PSLE stress finally coming to an end? MOE considers reforms
21:58

Wealth Tracker: Bitcoin slides to US$83,000 - Is now the time to buy the dip? Or is another crypto winter ahead?
17:44

What’s Trending: Today you turn Chinese?... to K-pop fans spend $70,000 for an empty parcel
17:47